&w=3840&q=100)
Ambuja Cements share price gains 5% in trade; What's behind rally?
The company's market capitalisation stood at ₹1,36,223.04 crore. Its 52-week high was at ₹706.85 per share and 52-week low was at ₹452.9 per share.
What led to a rally in Ambuja Cements stock?
The stock gained after the company informed that it successfully commissioned a 2.4 Million Ton Per Annum (MTPA) brownfield expansion of a cement unit in Sankrail, West Bengal.
"We would like to inform that the Company has successfully commissioned 2.4 Million Ton Per Annum (MTPA) brownfield expansion of Cement Unit in Sankrail, West Bengal," the filing read.
Ambuja Cements Q4 results
Ambuja Cements, in Q4, reported a 9 per cent decline in consolidated net profit ₹956.27 crore, as compared to ₹1,050.58 crore reported during the same period last year. Sequentially, consolidated net profit more than halved from ₹2,115.33 crore.
Revenue from operations, however, grew by 11.6 per cent year-on-year (Y-o-Y) to ₹9,802.47 crore from ₹8,785.28 crore. On a quarter-on-quarter (Q-o-Q) basis, revenue rose by 16.5 per cent from ₹8,415.31 crore.
Total expenses, meanwhile, also grew 14 per cent at ₹8,821.70 crore, compared to ₹7,747.41 crore reported during the same period last year. Sequentially, expenses rose by 6 per cent from ₹8,347.68 crore in Q3 FY25.
Ambuja Cements' consolidated quarterly earnings before interest, taxes, depreciation, and amortisation (Ebitda) were the highest at ₹1,868 crore, up 10 per cent Y-o-Y. However, the margin slipped to 18.9 per cent from 19.1 per cent during the year-ago period.
About Ambuja Cements
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
Bajaj Housing Finance's net profit up 20.86% in Q1 FY26
NEW DELHI: Bajaj Housing Finance has reported a growth of 20.86 per cent in its net consolidated profit in the first quarter of the financial year 2025-26. The company's profit after tax stood at ₹583.30 crore in Q1 FY26 as against ₹482.61 crore it registered in the corresponding quarter of the previous fiscal, the company said in a BSE filing. The company's net consolidated total income stood at ₹2,618.45 crore in Q1 FY26, a growth of 18.55 per cent from ₹2,208.73 crore it recorded in the similar quarter last year. As of June 30, 2025, the company's net worth stood at ₹20,508.37 crore, debt-equity ratio was 4.31, total debts to total assets was 0.81, gross non-performing assets (NPA) was 0.30%, net NPA was 0.13%, capital to risk-weighted assets ratio was 26.94% and liquidity coverage ratio was 210.57%. The company's assets under management (AUM) grew by 24 per cent to ₹1.20,420 crore as of 30 June 2025 from ₹97,071 crore as of 30 June 2024. Loan losses and provisions for Q1 FY26 was ₹41 crore as against ₹10 crore in Q1 FY25. Provisioning coverage ratio on stage 3 assets at 56%.
&w=3840&q=100)
Business Standard
3 hours ago
- Business Standard
Discovery Global Management exits SpiceJet, sells 2.2% stake for ₹119 crore
Global macro hedge fund Discovery Capital Management on Wednesday exited SpiceJet by selling its entire 2.2 per cent stake in the domestic carrier for₹ 119 crore through an open market transaction. The US-based Discovery Capital Management through its affiliate Discovery Global Opportunity (Mauritius) Ltd offloaded 3,11,53,621 shares, representing a 2.20 per cent stake in Gurugam-based SpiceJet, as per the bulk deal data on the BSE. The transaction was executed at an average price of ₹38.14 apiece, taking the total deal value to ₹118.82 crore. Meanwhile, Plutus Wealth Management bought 2.45 crore shares or 1.73 per cent stake in SpiceJet for ₹93.39 crore. The shares were picked up at an average price of ₹38.12 apiece. Following the stake buy, Plutus Wealth Management's holding in SpiceJet rose to 4.44 per cent from 2.71 per cent. Details of other buyers of SpiceJet shares could not be ascertained on the bourse. SpiceJet rose 5.75 per cent to close at ₹40.29 apiece on the BSE. On Wednesday, the Supreme Court dismissed a plea of KAL Airways and Kalanithi Maran seeking damages of over ₹1,300 crore from SpiceJet in a long-standing share transfer dispute. A bench of Justices P S Narasimha and A S Chandurkar upheld the Delhi High Court's order of May 23 dismissing their plea on grounds of delay. KAL Airways and Kalanithi Maran had initially sought damages of over ₹1,300 crore during the arbitration proceedings. Maran and KAL Airways were former promoters of SpiceJet.
The Hindu
3 hours ago
- The Hindu
Natco Pharma to acquire stake in South African firm Adcock Ingram for ₹2,000 crore
Natco Pharma has made an offer to acquire nearly 36% stake in South African pharmaceutical company Adcock Ingram Holdings (AIHL) for $226 million (around ₹2,000 crore). The proposal to acquire the stake from minority shareholders in an all cash deal is a strategic investment aimed at to expanding geographic footprint in South Africa, Natco said on Wednesday. Founded in 1890, AIHL has a diverse product portfolio, from generic and branded formulations, critical-care hospital products to consumer and home-care products. It operates across four segments -prescription, consumer, OTC and hospitals. The acquisition is expected to be completed by 2025. Post-acquisition, AIHL will continue to operate as a private South African business with Bidvest holding 64.25% and Natco 35.75%, including a prior held 0.80% stake, in the company. Post-transaction, Natco will consolidate 35.75% of AIHL net profits in its financial results. AIHL clocked revenue of $536 million in the financial year June 2024 and profit after tax of $45 million. 'Adcock Ingram is a respectable pharmaceutical company with well-recognised brands and products and maintains a leading position in the South African pharmaceutical market. The proposed transaction will provide Natco Pharma with a well-established entry into the Southern African market. It will also allow us to tap into new revenue streams and expand our footprint in one of the largest and growing emerging markets, while providing a gateway to the African continent,' CEO and Vice-Chairman Rajeev Nannapaneni said. Besides the acquisition, Natco Pharma Board also approved a proposal to incorporate a wholly owned subsidiary in South Africa with an investment of up to Rs.2,100 crore by this year to enter new geographies for growth and increased profitability. It also approved a proposal to liquidate wholly owned subsidiary Time Cap Overseas (TCOL), and directly hold the investment in step down subsidiary NatcoFarma do Brasil. Natco shares closed 2.01% higher at ₹1,034.75 apiece on the BSE.
